gilead glp-1 Can adding Novo's to Gilead's NASH combo help hit fatty liver disease? New trial aims to find out it’s the perfect companion for anyone using GLP Frontiers | GLP-1 receptor agonists
Description
Exendin(9-39) has been widely used as a GLP-1 receptor antagonist, yet only in short-term human studies
10.1007/s12325-010-0110-x 41 FriedlanderR
10.1111/j.1728-4465.2010.00250.x [DOI] [PubMed] [Google Scholar] 6
They slow gastric emptying and reduce appetite and food intake
Existing data sources in clinical epidemiology: laboratory information system databases in Denmark
Circulation Research
